From a preclinical viewpoint, additional research is needed to assess the neuroprotective agent in animals receiving long-term anti-autistic medication treatment
LegitScript verified Active members: 150,000+ The full medication menu includes compounded semaglutide and tirzepatide injections, GLP-1 liquid drops, GLP-1 lozenges, oral semaglutide liposomal tablets, the FDA-approved Foundayo pill, brand-name Wegovy and Zepbound, plus several non-GLP-1 weight-loss medications like metformin, naltrexone-bupropion, and topiramate combinations
These findings are supported by a prospective study on VLCKD intervention [135] showing an average weight loss of approximately 20 kg over 4 months, primarily due to reductions in total and visceral FM (~ 85% of total loss), while LMB and muscle strength were preserved
Van Houten, B., Woshner, V
Members access regularly updated protocol recommendations based on the most recent clinical data, community experience, and expert analysis
M., Tungate Lopez, S
.webp)
